Tesla shares were down for a second straight day on Thursday, following more weak sales data and as CEO Elon Musk criticized ...

While new U.K. car registrations eked out a modest 1.6% increase overall for May, sales of the Tesla brand plummeted 36% year-on-year to just 2,016 vehicles. The EV maker has been battling a public re ...

As Elon Musk pivots away from Washington and back to his companies including Tesla, experts say he will have to address ...

Tesla’s fortunes picked up somewhat in May, thanks to the sales of its new Model Y, which hit the market in April.

Tesla's high-profile leader, Elon Musk, has pushed the company into many lucrative verticals, everything from electric ...

Tesla shares fell close to 4% Wednesday as reports indicated the electric vehicle maker's sales continued to slip in some key markets last month.

Tesla, once synonymous with electric vehicles, is now facing a series of headwinds that are shaking its dominance in the EV ...

Tesla struggles in new Euro NCAP driver-assistance tests with Autopilot name deemed “inappropriate” by safety body ...

The automaker’s Australian electric vehicle sales hit their highest level in nearly 12 months in May — a bright spot as it ...

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

Advertising powered by artificial intelligence is a core part of Chief Executive Mark Zuckerberg's vision for the company's future. BioNTech and Bristol Myers Squibb have agreed to jointly develop and ...

Some senior Tesla executives were alarmed last year when Elon Musk denied a Reuters report that the company had killed a ...